181 related articles for article (PubMed ID: 28816270)
1. [Clinical value of fluorescence in situ hybridization positive of exfoliated urothelial cells in urothelial carcinoma].
Liu JY; Peng X; Ning XH; Li T; Peng SH; Wang JY; Liu SJ; Ding Y; Cai L; Gong K
Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Aug; 49(4):585-589. PubMed ID: 28816270
[TBL] [Abstract][Full Text] [Related]
2. Fluorescence in situ hybridization (FISH) in the diagnosis of bladder and upper tract urothelial carcinoma: the largest single-institution experience to date.
Gomella LG; Mann MJ; Cleary RC; Hubosky SG; Bagley DH; Thumar AB; McCue PA; Lallas CD; Trabulsi EJ
Can J Urol; 2017 Feb; 24(1):8620-8626. PubMed ID: 28263126
[TBL] [Abstract][Full Text] [Related]
3. [Numerical aberrations of chromosomes 11 and 17 detected by fish--fluorescence in situ hybridization combined with cytology in exfoliated cells from voided urine in patients with urothelial carcinoma of the bladder].
Asali MG; Kaneti J; Manor E
Harefuah; 2007 Dec; 146(12):914-9, 1000. PubMed ID: 18254439
[TBL] [Abstract][Full Text] [Related]
4. [Clinical utility of fluorescence in situ hybridization improves the sensitivity in the diagnosis of upper urinary tract urothelial carcinoma].
Mu DW; Zhou LQ; Ding Y; He ZS; Wang Y; He Q; Yang XY
Beijing Da Xue Xue Bao Yi Xue Ban; 2010 Aug; 42(4):381-5. PubMed ID: 20721247
[TBL] [Abstract][Full Text] [Related]
5. A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma.
Halling KC; King W; Sokolova IA; Meyer RG; Burkhardt HM; Halling AC; Cheville JC; Sebo TJ; Ramakumar S; Stewart CS; Pankratz S; O'Kane DJ; Seelig SA; Lieber MM; Jenkins RB
J Urol; 2000 Nov; 164(5):1768-75. PubMed ID: 11025767
[TBL] [Abstract][Full Text] [Related]
6. The Clinical Application of Fluorescence in Situ Hybridization in Diagnosing Urothelial Carcinoma.
Zhou H; Yan Y; Song L
Clin Lab; 2016 Oct; 62(10):2001-2009. PubMed ID: 28164542
[TBL] [Abstract][Full Text] [Related]
7. Utility of fluorescence in situ hybridization in the diagnosis of upper urinary tract urothelial carcinoma.
Luo B; Li W; Deng CH; Zheng FF; Sun XZ; Wang DH; Dai YP
Cancer Genet Cytogenet; 2009 Mar; 189(2):93-7. PubMed ID: 19215789
[TBL] [Abstract][Full Text] [Related]
8. The value of the UroVysion® FISH assay in the risk-stratification of patients with "atypical urothelial cells" in urinary cytology specimens.
Virk RK; Abro S; de Ubago JMM; Pambuccian SE; Quek ML; Wojcik EM; Mehrotra S; Chatt GU; Barkan GA
Diagn Cytopathol; 2017 Jun; 45(6):481-500. PubMed ID: 28397365
[TBL] [Abstract][Full Text] [Related]
9. Utility of fluorescence in situ hybridization as a non-invasive technique in the diagnosis of upper urinary tract urothelial carcinoma.
Marín-Aguilera M; Mengual L; Ribal MJ; Musquera M; Ars E; Villavicencio H; Algaba F; Alcaraz A
Eur Urol; 2007 Feb; 51(2):409-15; discussion 415. PubMed ID: 17010508
[TBL] [Abstract][Full Text] [Related]
10. UroVysion® multiprobe FISH in the triage of equivocal urinary cytology cases.
Bubendorf L; Piaton E
Ann Pathol; 2012 Dec; 32(6):e52-6, 438-43. PubMed ID: 23244486
[TBL] [Abstract][Full Text] [Related]
11. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder.
Degtyar P; Neulander E; Zirkin H; Yusim I; Douvdevani A; Mermershtain W; Kaneti J; Manor E
Urology; 2004 Feb; 63(2):398-401. PubMed ID: 14972510
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of fluorescence in situ hybridization as an ancillary tool to urine cytology in diagnosing urothelial carcinoma.
Veeramachaneni R; Nordberg ML; Shi R; Herrera GA; Turbat-Herrera EA
Diagn Cytopathol; 2003 Jun; 28(6):301-7. PubMed ID: 12768634
[TBL] [Abstract][Full Text] [Related]
13. The utility of fluorescence in situ hybridization for detection of bladder urothelial carcinoma in routine clinical practice.
Kwak KW; Kim SH; Lee HM
J Korean Med Sci; 2009 Dec; 24(6):1139-44. PubMed ID: 19949672
[TBL] [Abstract][Full Text] [Related]
14. [Detection of urothelial carcinoma of the urinary bladder by multicolor fluorescence in situ hybridization].
Zhang YG; Bi XG; Han YL; Cai Y; Xu X; Wu YP; Yang YL; Ma JH; Zhao P; Jia XM; Wang MR
Ai Zheng; 2007 Feb; 26(2):189-93. PubMed ID: 17298751
[TBL] [Abstract][Full Text] [Related]
15. Utility of a multiprobe fluorescence in situ hybridization assay in the detection of superficial urothelial bladder cancer.
Marín-Aguilera M; Mengual L; Ribal MJ; Burset M; Arce Y; Ars E; Oliver A; Villavicencio H; Algaba F; Alcaraz A
Cancer Genet Cytogenet; 2007 Mar; 173(2):131-5. PubMed ID: 17321328
[TBL] [Abstract][Full Text] [Related]
16. Prospective evaluation of fluorescence
Lin T; Liu Z; Liu L; Yang L; Han P; Zhang P; Wei Q
Oncol Lett; 2017 May; 13(5):3928-3934. PubMed ID: 28529600
[TBL] [Abstract][Full Text] [Related]
17. Fluorescence in situ hybridization for detecting urothelial carcinoma: a clinicopathologic study.
Caraway NP; Khanna A; Fernandez RL; Payne L; Bassett RL; Zhang HZ; Kamat A; Katz RL
Cancer Cytopathol; 2010 Oct; 118(5):259-68. PubMed ID: 20665656
[TBL] [Abstract][Full Text] [Related]
18. [Value of fluorescence in situ hybridization of urine exfoliative cells in diagnosis of urinary bladder neoplasms].
Chen N; Gong J; Zeng H; Wei Q; Zhu YC; Chen M; Zhou Q
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Jan; 42(1):109-13. PubMed ID: 21355314
[TBL] [Abstract][Full Text] [Related]
19. Urinary fluorescence in situ hybridization assay for detecting urothelial carcinoma in Taiwanese patients.
Chuang KL; Chuang HC; Ng KF; Chang YH; Wu CT; Chuang CK; Liao SK; Pang ST
BJU Int; 2010 May; 105(10):1413-6. PubMed ID: 19818076
[TBL] [Abstract][Full Text] [Related]
20. Comparison of urinary cytology and fluorescence in situ hybridization in the detection of urothelial neoplasia: An analysis of discordant results.
McHale T; Ohori NP; Cieply KM; Sherer C; Bastacky SI
Diagn Cytopathol; 2019 Apr; 47(4):282-288. PubMed ID: 30417563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
